258 related articles for article (PubMed ID: 32559461)
1. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids.
Koundouros N; Karali E; Tripp A; Valle A; Inglese P; Perry NJS; Magee DJ; Anjomani Virmouni S; Elder GA; Tyson AL; Dória ML; van Weverwijk A; Soares RF; Isacke CM; Nicholson JK; Glen RC; Takats Z; Poulogiannis G
Cell; 2020 Jun; 181(7):1596-1611.e27. PubMed ID: 32559461
[TBL] [Abstract][Full Text] [Related]
2. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
3. Fcgamma RI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cells.
Tay HK; Melendez AJ
J Biol Chem; 2004 May; 279(21):22505-13. PubMed ID: 15007079
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway.
Li X; Chen G; Wang F; Guo X; Zhang R; Liu P; Dong L; Yu W; Wang H; Wang H; Yu J
Clin Transl Med; 2023 Nov; 13(11):e1483. PubMed ID: 37965796
[TBL] [Abstract][Full Text] [Related]
5. PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation.
Silva JM; Deuker MM; Baguley BC; McMahon M
Pigment Cell Melanoma Res; 2017 May; 30(3):353-367. PubMed ID: 28233937
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling.
He B; Bie Q; Zhao R; Yan Y; Dong G; Zhang B; Wang S; Xu W; Tian D; Hao Y; Zhang Y; Zhao M; Xiong H; Zhang B
Cell Rep Med; 2024 May; 5(5):101510. PubMed ID: 38614093
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cytosolic phospholipase A2 phosphorylation and eicosanoid production by colony-stimulating factor 1.
Xu XX; Rock CO; Qiu ZH; Leslie CC; Jackowski S
J Biol Chem; 1994 Dec; 269(50):31693-700. PubMed ID: 7989342
[TBL] [Abstract][Full Text] [Related]
8. Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin.
Cufí S; Corominas-Faja B; Lopez-Bonet E; Bonavia R; Pernas S; López IÁ; Dorca J; Martínez S; López NB; Fernández SD; Cuyàs E; Visa J; Rodríguez-Gallego E; Quirantes-Piné R; Segura-Carretero A; Joven J; Martin-Castillo B; Menendez JA
Oncotarget; 2013 Sep; 4(9):1484-95. PubMed ID: 23986086
[TBL] [Abstract][Full Text] [Related]
9. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release.
Huwiler A; Johansen B; Skarstad A; Pfeilschifter J
FASEB J; 2001 Jan; 15(1):7-9. PubMed ID: 11099485
[TBL] [Abstract][Full Text] [Related]
10. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
11. The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.
Tanaka H; Yoshida M; Tanimura H; Fujii T; Sakata K; Tachibana Y; Ohwada J; Ebiike H; Kuramoto S; Morita K; Yoshimura Y; Yamazaki T; Ishii N; Kondoh O; Aoki Y
Clin Cancer Res; 2011 May; 17(10):3272-81. PubMed ID: 21558396
[TBL] [Abstract][Full Text] [Related]
12. Activation of phospholipase A2 by complement C5b-9 in glomerular epithelial cells.
Panesar M; Papillon J; McTavish AJ; Cybulsky AV
J Immunol; 1997 Oct; 159(7):3584-94. PubMed ID: 9317158
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE.
Currie S; Roberts EF; Spaethe SM; Roehm NW; Kramer RM
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):923-8. PubMed ID: 7818499
[TBL] [Abstract][Full Text] [Related]
14. Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
Young CD; Pfefferle AD; Owens P; Kuba MG; Rexer BN; Balko JM; Sánchez V; Cheng H; Perou CM; Zhao JJ; Cook RS; Arteaga CL
Cancer Res; 2013 Jul; 73(13):4075-85. PubMed ID: 23633485
[TBL] [Abstract][Full Text] [Related]
15. Extracellular calcium regulates HeLa cell morphology during adhesion to gelatin: role of translocation and phosphorylation of cytosolic phospholipase A2.
Crawford JR; Jacobson BS
Mol Biol Cell; 1998 Dec; 9(12):3429-43. PubMed ID: 9843579
[TBL] [Abstract][Full Text] [Related]
16. Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes.
Xu J; Weng YI; Simonyi A; Krugh BW; Liao Z; Weisman GA; Sun GY
J Neurochem; 2002 Oct; 83(2):259-70. PubMed ID: 12423237
[TBL] [Abstract][Full Text] [Related]
17. Role of Ca2+-ATPase inhibitors in activation of cytosolic phospholipase A2 in human polymorphonuclear neutrophils.
Zhang H; Garlichs CD; Mügge A; Daniel WG
Eur J Pharmacol; 1999 Jan; 364(2-3):229-37. PubMed ID: 9932728
[TBL] [Abstract][Full Text] [Related]
18. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
19. Expression of a mutant Gi2 alpha subunit inhibits ATP and thrombin stimulation of cytoplasmic phospholipase A2-mediated arachidonic acid release independent of Ca2+ and mitogen-activated protein kinase regulation.
Winitz S; Gupta SK; Qian NX; Heasley LE; Nemenoff RA; Johnson GL
J Biol Chem; 1994 Jan; 269(3):1889-95. PubMed ID: 8294438
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils.
Syrbu SI; Waterman WH; Molski TF; Nagarkatti D; Hajjar JJ; Sha'afi RI
J Immunol; 1999 Feb; 162(4):2334-40. PubMed ID: 9973512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
